Kymera Therapeutics, Inc.KYMRNASDAQ
Loading
Gross Profit Over TimeContracting
Percentile Rank43
3Y CAGR-5.8%
5Y CAGR+2.9%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
-5.8%/yr
Annual compound
5Y CAGR
+2.9%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $39.20M | -16.7% |
| 2024 | $47.07M | -40.1% |
| 2023 | $78.59M | +67.8% |
| 2022 | $46.83M | -35.7% |
| 2021 | $72.83M | +114.0% |
| 2020 | $34.03M | +1513.8% |
| 2019 | $2.11M | +1128.8% |
| 2018 | $-205000.00 | - |